Coronary revascularization for myocardial ischemia.

Comparison between Revascularization and Optimal Medical Therapy in Patients with Stable Angina Pectoris

Background and Purpose: Regarding usefulness of revascularization versus optimal medical therapy in patients with stable angina pectoris, data are challenging. The aim of this 12-month follow-up study was to compare the survival benefit associated with revascularization versus optimal medical therapy on the patients with stable angina pectoris. Materials and Methods: A prospective clinical s...

Protecting the Myocardial Cell During Coronary Revascularization

Background—Using the ischemic myocardial cell as a paradigm, competitive coronary revascularization technologies will be analyzed for their potential in causing additional myocardial cell damage during the course of therapeutic procedures. Methods and Results—Percutaneous coronary intervention (PCI) using balloon and/or stent (bare metal or coated) approaches may be associated with myonecrosis ...

Ischemia-Guided Myocardial Revascularization: the Oculo-ischemic Reflex

DOI: 10.5935/abc.20140047 In stable coronary artery disease, the indication for revascularization procedures based on the anatomical detection of stenotic coronary lesions, regardless of clinical findings, has been called ‘oculostenotic reflex’. That expression was ironically created by Topol E. and Nissen S., and aimed at warning about the fact that not every obstruction has to be approached i...

Recurrent angina after coronary revascularization: a clinical challenge.

Coronary revascularization procedures by means of percutaneous coronary interventions or coronary artery bypass graft surgeries are performed worldwide daily for the symptomatic treatment of patients with myocardial ischaemia. Nevertheless, angina remains a significant clinical problem. Management of angina recurring or persisting after coronary revascularization is particularly challenging. Th...

“The Prehospital Administration of Thrombolytic Therapy with Urgent Culprit Artery Revascularization (PATCAR) trial was designed to evaluate half-dose fibrinolysis coupled with urgent coronary revascularization in patients with ST segment elevation myocardial infarction versus primary percutaneous coronary intervention.”